Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -17.425% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCN(CC)CCn1c(=S)[nH]c2ccc(Cl)cc2c1=O
[b] Cc1cc(C)n2c(SCCC(C)C)nnc2n1
[c] Cc1ccc(-c2nnc(N(C)C(=O)c3cccnc3)s2)cc1
Answer: c. Cc1ccc(-c2nnc(N(C)C(=O)c3cccnc3)s2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2nnc(N(C)C(=O)c3cccnc3)s2)cc1
Cc1ccc(-c2nnc(N(C)C(=O)c3cccnc3)s2)cc1
N-methyl-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]pyridine-3-carboxamide